#RAJKAMedal Rajka medal and prize: the winner among 4 excellent applicants originating from Indonesia, Ireland, Japan and Madagascar, is Dr Ge PENG, MD, PhD, Associate Professor at the Atopy Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. Brief description of the research project Atopic dermatitis is a common long-term skin condition that can […]
Read More
We are pleased to announce the third edition of the J-DAC conference, dedicated to exploring the “One Health” approach to atopic dermatitis. This upcoming edition will focus specifically on one of the most significant recent therapeutic advancements in the field: Janus kinase inhibitors (JAKi). The program offers a unique opportunity to bridge human and veterinary […]
Read More
S. aureus and Eczema Herpeticum: A Laboratory Paradox, a Bedside Emergency Eczema herpeticum, or Kaposi-Juliusberg syndrome caused by HSV-1, is one of the situations in atopic dermatitis where clinical hesitation can be dangerous. Dermatologists who have seen severe cases remember the picture well: sudden painful monomorphic vesicles or punched-out erosions on eczematous skin, fever, facial […]
Read More
Can inflamed AD skin become a gateway for topical biologics?➜ DOI: 10.34133/bmr.0368Why it matters:A thermosensitive hyaluronic acid/Pluronic hydrogel delivered mesenchymal stromal cell-derived extracellular vesicles through AD-like lesional skin in mice, improving dermatitis scores, epidermal thickening, mast-cell infiltration, cytokine expression, barrier markers, and oxidative stress.Context and caution:The most intriguing point is that damaged AD skin allowed EV [...] Read More
Dr. Roberto TAKAOKA’s visit to Manaus launches a vital new support network while opening doors to unique environmental research on atopic dermatitis. Last month, Dr Roberto TAKAOKA, Vice-President of ISAD, visited Manaus in the heart of Brazil’s Amazon region as part of a project by the Brazilian Atopic Dermatitis Association (AADA) to establish new support […]
Read More
The success of the second call for the ISAD-GADA Fellowship was highlighted, with seven applicants from six different countries (Ethiopia, Ghana, Lebanon, Madagascar, Malaysia and Nepal). A heartfelt thank you to everyone who applied. We were genuinely encouraged by the volume and quality of submissions we received. We are delighted to inform that Dr Naina […]
Read More
From “Response” to “Reassurance” Topical corticosteroids (TCS) remain the cornerstone of atopic dermatitis (AD) management worldwide. Yet, despite decades of clinical use, a paradox persists: while clinicians rely on TCS as first-line therapy, many patients remain uncertain, and sometimes fearful, about how to use them safely over time. This tension is increasingly visible in discussions […]
Read More
New Strategic Partnership The International Society of Atopic Dermatitis (ISAD) is proud to announce a new exclusive strategic partnership with Umer Doctor, China’s premier professional platform for dermatologists. This collaboration marks a significant milestone as we prepare for the 16th Georg RAJKA International Symposium on Atopic Dermatitis, taking place in Beijing. Why This Partnership Matters […]
Read More
Fast runners or long-distance champions? Rethinking AD therapy trajectories➜ DOI: 10.1111/all.70395A new Allergy editorial proposes an athletic metaphor for AD therapies: JAK inhibitors as “sprinters,” IL-4/IL-13 biologics as “mid-distance runners,” and emerging immune-resetting approaches as “marathoners.” An attractive framework—but perhaps the key question is not only how therapies run, but how disease evolves in each patient. [...] Read More
Pediatric Atopic Dermatitis Guidelines in 2026:Convergence of Evidence, Divergence of Practice The recent JAAD 2026 guidelines on pediatric atopic dermatitis DOI: 10.1016/j.jaad.2026.02.114, led by the late Robert Sidbury, marks an important milestone: it is the first fully evidence-graded, pediatric-specific update in the era of biologics and JAK inhibitors. Built on a strict GRADE methodology and largely restricted […]
Read More